SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-24-073623
Filing Date
2024-06-20
Accepted
2024-06-20 21:00:17
Documents
1
Group Members
FORESITE CAPITAL MANAGEMENT VI, LLCJAMES TANANBAUM

Document Format Files

Seq Description Document Type Size
1 SC 13G tm2417376d1_sc13g.htm SC 13G 75962
  Complete submission text file 0001104659-24-073623.txt   77853
Mailing Address 900 LARKSPUR LANDING CIRCLE, SUITE 150 LARKSPUR CA 94939
Business Address 900 LARKSPUR LANDING CIRCLE, SUITE 150 LARKSPUR CA 94939 415-877-4887
Foresite Capital Fund VI LP (Filed by) CIK: 0001932516 (see all company filings)

IRS No.: 881506258 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 1701-1702, CHINA CENTRAL OFFICE TOWER 1 NO. 81 JIANGUO ROAD, CHAOYANG DISTRICT BEIJING F4 100025
Business Address 1701-1702, CHINA CENTRAL OFFICE TOWER 1 NO. 81 JIANGUO ROAD, CHAOYANG DISTRICT BEIJING F4 100025 86 10 6561 8789
CASI Pharmaceuticals, Inc. (Subject) CIK: 0001962738 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-94039 | Film No.: 241058194
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)